KRBP
Price:
$0.9201
Market Cap:
$1.42M
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, as well as a research and development collaboration agreement with Molipharma, S.R.L. The company also has strategic alliance agreement ...[Read more]
Industry
Biotechnology
IPO Date
2020-10-16
Stock Exchange
NASDAQ
Ticker
KRBP
According to Kiromic BioPharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.21M. This represents a change of -44.05% compared to the average of 23.61M of the last 4 quarters.
The mean historical Enterprise Value of Kiromic BioPharma, Inc. over the last ten years is 25.42M. The current 13.21M Enterprise Value has changed 5.10% with respect to the historical average. Over the past ten years (40 quarters), KRBP's Enterprise Value was at its highest in in the September 2020 quarter at 82.86M. The Enterprise Value was at its lowest in in the December 2021 quarter at -1140917.40.
Average
25.42M
Median
26.77M
Minimum
-7429538.70
Maximum
52.02M
Discovering the peaks and valleys of Kiromic BioPharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 21.86%
Maximum Annual Enterprise Value = 52.02M
Minimum Annual Increase = -257.71%
Minimum Annual Enterprise Value = -7429538.70
Year | Enterprise Value | Change |
---|---|---|
2023 | 13.29M | 13.45% |
2022 | 11.72M | -257.71% |
2021 | -7429538.70 | -114.28% |
2020 | 52.02M | 21.86% |
2019 | 42.69M | 6.07% |
The current Enterprise Value of Kiromic BioPharma, Inc. (KRBP) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.86M
5-year avg
22.46M
10-year avg
25.42M
Kiromic BioPharma, Inc.’s Enterprise Value is greater than Quoin Pharmaceuticals, Ltd. (-243459.00), greater than Allarity Therapeutics, Inc. (-12736306.00), greater than Virax Biolabs Group Limited (4.23M), less than Biodexa Pharmaceuticals Plc (734.63M), greater than Zura Bio Limited (-39351752.00), greater than Altamira Therapeutics Ltd. (498.26K), less than Immix Biopharma, Inc. (41.09M), greater than Enveric Biosciences, Inc. (193.53K), greater than Palisade Bio, Inc. (-2842535.00), greater than CNS Pharmaceuticals, Inc. (-733373.00), greater than eFFECTOR Therapeutics, Inc. (4.74M), greater than Navidea Biopharmaceuticals, Inc. (-2595051.00), greater than Sonnet BioTherapeutics Holdings, Inc. (4.67M), less than Sigilon Therapeutics, Inc. (42.21M), less than Reviva Pharmaceuticals Holdings, Inc. (40.86M), greater than ZyVersa Therapeutics, Inc. (2.55M), less than Unicycive Therapeutics, Inc. (39.46M),
Company | Enterprise Value | Market cap |
---|---|---|
-243459.00 | $2.87M | |
-12736306.00 | $4.39M | |
4.23M | $7.60M | |
734.63M | $927.02M | |
-39351752.00 | $148.87M | |
498.26K | $1.13M | |
41.09M | $59.69M | |
193.53K | $3.31M | |
-2842535.00 | $4.84M | |
-733373.00 | $6.21M | |
4.74M | $941.00 | |
-2595051.00 | $10.01K | |
4.67M | $4.69M | |
42.21M | $56.22M | |
40.86M | $46.34M | |
2.55M | $2.67M | |
39.46M | $71.00M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kiromic BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kiromic BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Kiromic BioPharma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Kiromic BioPharma, Inc. (KRBP)?
What is the 3-year average Enterprise Value for Kiromic BioPharma, Inc. (KRBP)?
What is the 5-year average Enterprise Value for Kiromic BioPharma, Inc. (KRBP)?
How does the current Enterprise Value for Kiromic BioPharma, Inc. (KRBP) compare to its historical average?